In our study, we investigated the efficiency of LPE-polyflavonoids in alleviating DM and enhancing the pancreatic and liver functions by regulating the expressions of PI3K, p-AKT, and FOXO1 as key modulators for controlling DM. The gene discussed is FOXO1; the disease is diabetes mellitus.